• About us
    • Who we are
    • Our strategy
    • How we are funded
    • Our people
    • Governance and structure
    • Reports and statements
    • Suppliers
  • Our strategy
    • Our strategy
    • Global health
    • Neurodegeneration
    • Rare Disease
    • Respiratory health
  • Working with us
    • Support for MRC researchers
    • Helping charities
    • Our partners
    • Available technologies
    • Advise & Connect: Covid-19
  • Funding
    • LifeArc Ventures
    • Rare disease translational challenges
    • Development Gap Fund
    • Current funding opportunities
  • Capabilities
    • Drug discovery
    • Antibody humanisation
    • IP management and technology transfer
    • Diagnostics development
  • Careers
    • Working at LifeArc
    • Our culture
    • Benefits and rewards
    • Students and fellows
    • How to apply
    • Job vacancies
  • News
    • Latest news
    • Case studies
    • Reports and publications
    • Newsletter

Rare disease translational challenges

We help scientists progress their promising research into rare disease
HomeOur strategyRare DiseaseRare disease translational challenges
Grants, funding and support for academics
Translational Rare Disease Centres
£40 million to build on the UK’s rich, rare disease research base. (Closed to new applications)
Joint funding call: Funding for Epidermolysis Bullosa
LifeArc and DEBRA Austria in joint call for projects to develop therapeutics for any type of Epidermolysis Bullosa - apply by 10 September 2023
Philanthropic Fund
Grants and funding for researchers working to advance new treatments and diagnostics for rare diseases
Muscular Dystrophy Translational Research Fund
A one-off, joint £1m fund in association with Muscular Dystrophy UK (MDUK)
LifeArc Gene Therapy Innovation Fund
£5m annual fund for gene therapy technologies, which includes support from the world-class network of Innovation Hubs for Gene Therapies
LifeArc & GOSH Charity Fund
Joint funding scheme for GOSH researchers to drive their discoveries towards new tests and treatments for childhood rare diseases
LifeArc & Action Medical Research Joint Fund
Annual joint funding round of up to £1 million (closed 14 June 2023)
Scottish CSO Fund
A joint funding call made in 2020, which provided £300,000 to fund Scottish translational research into rare diseases
Quick links
  • Newsletter
  • Privacy policy
  • Cookie policy
  • Modern slavery statement
  • Sitemap
  • Contact us
Follow us
Get in touch
Lynton House
7-12 Tavistock Square
London WC1H 9LT UK

+44 (0)20 7391 2700
LifeArc is a charity registered with the Charity Commission for England and Wales no. 1015243 and a charity registered in Scotland with the Office of the Scottish Charity Regulator no. SC037861. LifeArc is a company limited by guarantee no. 2698321 incorporated in England and Wales. | © LifeArc 2023
Web design by TWK